According to the data available with Pharmaceutical Export Promotion Council (Pharmexcil), the cost of paracetamol has gone up from Rs 250-...

Morepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage man...

Pantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux.

Pharma firm Morepen Laboratories today said it is preparing to sell anti-asthmatic drug Montelukast in European and North American markets.

Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...

Drug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...

Drug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules.

Indian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.

"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...

This is the first time in the recent years that the Indian pharma exports saw single digit growth in dollar terms.

Glenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.

Glenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg) on "off-odour" complaints.

Dr Reddy's Laboratories has launched its generic Montelukast Sodium oral granules used for treating asthma and seasonal allergies in the US...

New Delhi Drug firms Aurobindo Pharma and Glenmark have received approval from the US health regulator to manufacture and market generic mo...

Aurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.

Indian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...

Glenmark said it has received tentative approval from the US health regulator to market its tablets used for treating asthma and seasonal a...